Work

Histology-agnostic approvals for antibody–drug conjugates in solid tumours: is the time ripe?

Year: 2022

Type: article

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2022.04.039

Authors: Chiara Corti, Gabriele Antonarelli, Carmine Valenza, Eleonora Nicolò, Hope Rugo, Javier Cortés, Nadia Harbeck, Lisa A. Carey, Carmen Criscitiello, Giuseppe Curigliano

Institutions: University of Milan, European Institute of Oncology, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Hospital Quirónsalud Barcelona, IDCQ Hospitales y Sanidad, S.L.U., Universidad Europea de Madrid, LMU Klinikum, Ludwig-Maximilians-Universität München, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4282929942

FWCI: 2.058

Cites: 99

Cited by: 19

Related to: 10